"The Global Beta Glucan Market valued at USD 702.6 million in 2024, is expected to grow by 7.3% CAGR to reach market size worth USD 1,451.2 million by 2034."
The Beta Glucan market is witnessing robust growth driven by rising global demand for functional and immune-boosting ingredients in food, healthcare, and personal care industries. Beta glucans are naturally occurring polysaccharides found in oats, barley, yeast, mushrooms, and certain algae. They are increasingly recognized for their scientifically proven health benefits, including cholesterol reduction, immune modulation, gut health improvement, and blood sugar regulation. These properties have led to widespread application in functional foods, dietary supplements, pharmaceuticals, and even skincare. The COVID-19 pandemic significantly accelerated consumer interest in immune health, further propelling demand for beta glucan-enriched products. Moreover, regulatory support from bodies such as the U.S. FDA and the EFSA—especially for oat- and barley-based beta glucans—has strengthened the market's credibility. In regions like North America and Europe, consumers are already familiar with fiber and heart-health ingredients, while the Asia-Pacific market is catching up rapidly due to growing health awareness, higher disposable incomes, and the popularity of traditional medicinal mushrooms. As a result, beta glucans are becoming a central focus of clean-label, plant-based, and preventive nutrition trends.
The competitive landscape of the Beta Glucan market includes a mix of established ingredient manufacturers and biotech innovators focusing on product purity, extraction efficiency, and novel applications. Innovations such as microencapsulation, liposomal delivery, and fermentation-based extraction methods are being adopted to enhance the bioavailability and stability of beta glucans in diverse end-use products. In the pharmaceutical industry, beta glucans are being investigated as adjunct therapies in cancer treatment, vaccine enhancement, and antimicrobial resistance due to their immune-stimulating effects. In cosmetics, they are increasingly used in moisturizers, serums, and anti-aging formulations due to their barrier-repair and anti-inflammatory properties. Meanwhile, food and beverage manufacturers are developing a wide range of beta glucan-infused cereals, dairy alternatives, snacks, and beverages. Sustainability is also becoming a strategic priority, with companies exploring low-impact sourcing and production techniques. The overall market outlook remains optimistic, supported by growing consumer preference for natural, multifunctional ingredients and a surge in wellness-focused product innovations across sectors.
The cereals segment is currently the largest in the Beta Glucan market due to widespread use of oat- and barley-derived beta glucans in the food and beverage industry. These sources are highly favored for their established health claims, especially cholesterol-lowering properties, and are easily incorporated into cereals, dairy alternatives, and baked goods.
The food & beverages segment dominates the market, driven by rising consumer demand for functional and clean-label products. Beta glucans are increasingly used in heart-health foods, digestive wellness products, and immune-boosting beverages, supported by strong regulatory endorsements and growing awareness of preventive nutrition across developed and emerging markets.
The global demand for beta glucan is growing rapidly due to its scientifically validated role in enhancing immune function, lowering cholesterol, and stabilizing blood sugar levels. These health benefits make it a vital ingredient in preventive nutrition, boosting its presence in dietary supplements, functional foods, and wellness-focused beverages worldwide.
Oat- and barley-based beta glucans are witnessing high traction in the food and beverage sector. Their proven efficacy in cholesterol reduction has been officially recognized by major regulatory authorities, prompting their inclusion in breakfast cereals, dairy substitutes, and healthy snacks marketed under heart-health or digestive wellness claims.
Yeast-derived beta glucans are favored in pharmaceutical and nutraceutical applications due to their purity and potent immunomodulatory effects. Their usage is expanding in formulations targeting respiratory health, inflammation management, and recovery support from chronic illnesses, particularly in capsule, powder, and tablet formats.
Mushroom-based beta glucans are gaining visibility across North America and Asia, largely in traditional medicine and holistic wellness sectors. These variants are associated with antioxidant, anti-tumor, and gut-balancing properties, making them popular in natural immunity boosters, medicinal teas, and herbal supplements.
Beta glucans are being increasingly utilized in skincare due to their hydrating, anti-aging, and skin-barrier-restorative properties. Their bioactive profile supports wound healing, reduces redness, and enhances collagen production, making them a functional ingredient in facial serums, creams, and cosmeceutical formulations.
Asia-Pacific is emerging as the fastest-growing regional market for beta glucans, supported by growing consumer interest in preventive health, rising functional food demand, and the traditional use of medicinal mushrooms in countries like China, Japan, and South Korea.
Innovations in microencapsulation, liposomal delivery, and fermentation-based production are enhancing the bioavailability and shelf life of beta glucans. These advancements are enabling broader application in high-performance supplements, ready-to-drink beverages, and pharmaceutical-grade formulations.
Post-pandemic consumer trends emphasize daily immune support, boosting demand for beta glucan-fortified products like gummies, shots, powders, and immunity-boosting blends. These formats appeal to younger, health-conscious consumers prioritizing convenience, plant-based solutions, and science-backed wellness.
Companies in the beta glucan space are expanding strategic collaborations with food, pharma, and cosmetic firms to co-create formulations tailored to target-specific outcomes such as heart health, immunity, and skin repair, enhancing product efficacy and market penetration.
Regulatory recognition from global authorities like the FDA and EFSA has solidified the credibility of beta glucans. This has led to increased acceptance by manufacturers and consumers alike, particularly in regions where approved health claims influence purchasing behavior and product development strategies.
The North America Beta Glucan market demonstrated robust growth in 2024, driven by advancements in personalized medicine, the proliferation of digital health solutions, and increased investment in biotechnologies such as biosimilars, biologics CDMO, and AI-driven medical diagnostics. The market is set to expand further in 2025, with a healthy CAGR driven by the rise in chronic disease incidence, aging demographics, and government initiatives supporting pharmaceutical innovation. Other notable growth drivers to 2034 include advancements in therapeutics and diagnostics, including biomarkers and gene therapy, as well as expanding applications of AI in drug discovery and clinical decision-making. Regulatory approvals and strategic partnerships between key players are enabling faster commercialization of cutting-edge therapies and medical technologies. This Beta Glucan market growth trajectory reflects a dynamic market landscape, with innovation, demand for digital transformation, and regulatory adaptation playing pivotal roles.
The European Beta Glucan market witnessed steady growth in 2024, underpinned by increased funding for healthcare innovation, robust R&D, and the adoption of advanced diagnostic solutions. The Beta Glucan market is projected to continue growth in 2025, driven by the region's aging population and rising prevalence of autoimmune diseases. Key trends include the expansion of biostimulants and biotechnology, enhanced clinical trial imaging, and the adoption of AI-based diagnostic tools. Government policies promoting digital transformation in healthcare and incentives for eco-friendly medical plastics further support market expansion. Europe remains a hub for groundbreaking innovations, with collaborative frameworks facilitating faster regulatory approvals and market entry.
Asia-Pacific’s Beta Glucan market emerged as a high-growth region in 2024, driven by escalating demand for affordable healthcare solutions, rapid advancements in biotechnology, and the integration of AI in drug discovery and diagnostics. The Beta Glucan market is poised for exponential growth from 2025 to 2034, supported by increasing healthcare expenditure, a rising middle class, and government initiatives fostering local manufacturing of biosimilars and biologics. Expansion in therapeutics, cell therapy, and autoimmune disease diagnostics underscores the region's focus on precision medicine. Key markets such as China, India, and Japan are spearheading innovation, bolstered by favorable policies and global collaborations. The region’s adoption of digital therapeutics and clinical trial technologies marks a transformative phase, positioning Asia-Pacific as a critical player in the global Beta Glucan market landscape.
The Beta Glucan market across Middle East, Africa and South America displayed notable growth in 2024, particularly in emerging economies fueled by improving healthcare infrastructure and rising pharmaceutical investments. Growth from 2025 to 2034 is expected to accelerate, driven by increasing demand for affordable diagnostics, biosimilars, and vaccines to combat infectious and chronic diseases. Countries in the Middle East, Africa, and South America are witnessing significant advancements in areas like antimicrobial susceptibility testing, digital health solutions, and medical plastics. Government-led healthcare reforms, international partnerships, and a focus on localized production are key growth enablers. Additionally, the uptake of AI-driven diagnostics, eClinical solutions, and cancer therapeutics signals a shift towards innovative healthcare delivery. These trends highlight the potential of RoW markets as pivotal contributors to global healthcare evolution.
The research analyses the Beta Glucan parent market, derived market, intermediaries’ market, raw material market, and substitute market are all evaluated to better prospect the Beta Glucan market outlook. Geopolitical analysis, demographic analysis, and Porter’s five forces analysis are prudently assessed to estimate the best Beta Glucan market projections.
Recent deals and developments are considered for their potential impact on Beta Glucan's future business. Other metrics analyzed include the Threat of New Entrants, Threat of New Substitutes, Product Differentiation, Degree of Competition, Number of Suppliers, Distribution Channel, Capital Needed, Entry Barriers, Govt. Regulations, Beneficial Alternative, and Cost of Substitute in Beta Glucan market.
Beta Glucan trade and price analysis helps comprehend Beta Glucan's international market scenario with top exporters/suppliers and top importers/customer information. The data and analysis assist our clients in planning procurement, identifying potential vendors/clients to associate with, understanding Beta Glucan price trends and patterns, and exploring new Beta Glucan sales channels. The research will be updated to the latest month to include the impact of the latest developments such as the Russia-Ukraine war on the Beta Glucan market.
Beta Glucan Market Structure, Competitive Intelligence and Key Winning Strategies
The report presents detailed profiles of top companies operating in the Beta Glucan market and players serving the Beta Glucan value chain along with their strategies for the near, medium, and long term period.
OGAnalysis’ proprietary company revenue and product analysis model unveils the Beta Glucan market structure and competitive landscape. Company profiles of key players with a business description, product portfolio, SWOT analysis, Financial Analysis, and key strategies are covered in the report. It identifies top-performing Beta Glucan products in global and regional markets. New Product Launches, Investment & Funding updates, Mergers & Acquisitions, Collaboration & Partnership, Awards and Agreements, Expansion, and other developments give our clients the Beta Glucan market update to stay ahead of the competition.
Company offerings in different segments across Asia-Pacific, Europe, the Middle East, Africa, and South and Central America are presented to better understand the company strategy for the Beta Glucan market. The competition analysis enables users to assess competitor strategies and helps align their capabilities and resources for future growth prospects to improve their market share.
Beta Glucan Market Research Scope
• Global Beta Glucan market size and growth projections (CAGR), 2024- 2034
• Policies of USA New President Trump, Russia-Ukraine War, Israel-Palestine, Middle East Tensions Impact on the Beta Glucan Trade and Supply-chain
• Beta Glucan market size, share, and outlook across 5 regions and 27 countries, 2023- 2034
• Beta Glucan market size, CAGR, and Market Share of key products, applications, and end-user verticals, 2023- 2034
• Short and long-term Beta Glucan market trends, drivers, restraints, and opportunities
• Porter’s Five Forces analysis, Technological developments in the Beta Glucan market, Beta Glucan supply chain analysis
• Beta Glucan trade analysis, Beta Glucan market price analysis, Beta Glucan supply/demand
• Profiles of 5 leading companies in the industry- overview, key strategies, financials, and products
• Latest Beta Glucan market news and developments
The Beta Glucan Market international scenario is well established in the report with separate chapters on North America Beta Glucan Market, Europe Beta Glucan Market, Asia-Pacific Beta Glucan Market, Middle East and Africa Beta Glucan Market, and South and Central America Beta Glucan Markets. These sections further fragment the regional Beta Glucan market by type, application, end-user, and country.
Parameter | Detail |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2026-2032 |
Market Size-Units | USD million |
Market Splits Covered | By Type, By Source, By Application |
Countries Covered | North America (USA, Canada, Mexico) |
Analysis Covered | Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies |
Customization | 10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed |
Post-Sale Support | 4 analyst hours, available up to 4 weeks |
Delivery Format | The Latest Updated PDF and Excel Data file |
Regional Insights
North America Beta Glucan market data and outlook to 2034
United States
Canada
Mexico
Europe Beta Glucan market data and outlook to 2034
Germany
United Kingdom
France
Italy
Spain
BeNeLux
Russia
Asia-Pacific Beta Glucan market data and outlook to 2034
China
Japan
India
South Korea
Australia
Indonesia
Malaysia
Vietnam
Middle East and Africa Beta Glucan market data and outlook to 2034
Saudi Arabia
South Africa
Iran
UAE
Egypt
South and Central America Beta Glucan market data and outlook to 2034
Brazil
Argentina
Chile
Peru
* We can include data and analysis of additional coutries on demand
Who can benefit from this research
The research would help top management/strategy formulators/business/product development/sales managers and investors in this market in the following ways
1. The report provides 2024 Beta Glucan market sales data at the global, regional, and key country levels with a detailed outlook to 2034 allowing companies to calculate their market share and analyze prospects, uncover new markets, and plan market entry strategy.
2. The research includes the Beta Glucan market split into different types and applications. This segmentation helps managers plan their products and budgets based on the future growth rates of each segment
3. The Beta Glucan market study helps stakeholders understand the breadth and stance of the market giving them information on key drivers, restraints, challenges, and growth opportunities of the market and mitigating risks
4. This report would help top management understand competition better with a detailed SWOT analysis and key strategies of their competitors, and plan their position in the business
5. The study assists investors in analyzing Beta Glucan business prospects by region, key countries, and top companies' information to channel their investments.
Available Customizations
The standard syndicate report is designed to serve the common interests of Beta Glucan Market players across the value chain and include selective data and analysis from entire research findings as per the scope and price of the publication.
However, to precisely match the specific research requirements of individual clients, we offer several customization options to include the data and analysis of interest in the final deliverable.
Some of the customization requests are as mentioned below –
Segmentation of choice – Our clients can seek customization to modify/add a market division for types/applications/end-uses/processes of their choice.
Beta Glucan Pricing and Margins Across the Supply Chain, Beta Glucan Price Analysis / International Trade Data / Import-Export Analysis,
Supply Chain Analysis, Supply – Demand Gap Analysis, PESTLE Analysis, Macro-Economic Analysis, and other Beta Glucan market analytics
Processing and manufacturing requirements, Patent Analysis, Technology Trends, and Product Innovations
Further, the client can seek customization to break down geographies as per their requirements for specific countries/country groups such as South East Asia, Central Asia, Emerging and Developing Asia, Western Europe, Eastern Europe, Benelux, Emerging and Developing Europe, Nordic countries, North Africa, Sub-Saharan Africa, Caribbean, The Middle East and North Africa (MENA), Gulf Cooperation Council (GCC) or any other.
Capital Requirements, Income Projections, Profit Forecasts, and other parameters to prepare a detailed project report to present to Banks/Investment Agencies.
Customization of up to 10% of the content can be done without any additional charges.
Note: Latest developments will be updated in the report and delivered within 2 to 3 working days
By Type
By Source
By Application
By Geography
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Kerry Group plc.
Givaudan SA
Koninklijke DSM N.V.
Euglena Co. Ltd
Biotec Pharmacon ASA
Tate & Lyle plc.
Lesaffre Group
Kemin Industries, Inc.
ABF Ingredients
Super Beta Glucan
Garuda International, Inc.
July 11, 2025: Barrington Nutritionals highlighted Layn’s Galacan beta glucan at IFT FIRST 2025, emphasizing its superior water solubility and GRAS certification, marking a major stride for industrial adoption in food, personal care, and animal nutrition.
February 28, 2025: Layn Natural Ingredients opened an expanded biotechnology facility in Guangxi, China, and launched Galacan, a precision-fermented, highly bioavailable heteropolysaccharide aimed at outperforming conventional beta glucans in immune, gut, metabolic, and skin health.
February 26, 2025: Layn’s new precision‑fermentation plant began producing Galacan, featuring a unique spiral-cone structure for enhanced receptor affinity and absorption, and confirmed INCI certification for its use in nutricosmetics and topical applications.
July 4, 2025: Industry reporting noted that Cargill secured FDA approval for its barley-derived beta glucan in June 2024, enabling cardiovascular health claims—a key impetus for broader functional-food and supplement integration.
May 9, 2025: University of Queensland-backed research received A$5.6 million funding to develop oat-based beta glucan products beyond breakfast, such as noodles, rice, and pasta, indicating expansion into novel food applications.
1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Global Beta Glucan Market Review, 2024
2.1 Beta Glucan Industry Overview
2.2 Research Methodology
3. Beta Glucan Market Insights
3.1 Beta Glucan Market Trends to 2034
3.2 Future Opportunities in Beta Glucan Market
3.3 Dominant Applications of Beta Glucan, 2024 Vs 2034
3.4 Key Types of Beta Glucan, 2024 Vs 2034
3.5 Leading End Uses of Beta Glucan Market, 2024 Vs 2034
3.6 High Prospect Countries for Beta Glucan Market, 2024 Vs 2034
4. Beta Glucan Market Trends, Drivers, and Restraints
4.1 Latest Trends and Recent Developments in Beta Glucan Market
4.2 Key Factors Driving the Beta Glucan Market Growth
4.2 Major Challenges to the Beta Glucan industry, 2025- 2034
4.3 Impact of Wars and geo-political tensions on Beta Glucan supply chain
5 Five Forces Analysis for Global Beta Glucan Market
5.1 Beta Glucan Industry Attractiveness Index, 2024
5.2 Beta Glucan Market Threat of New Entrants
5.3 Beta Glucan Market Bargaining Power of Suppliers
5.4 Beta Glucan Market Bargaining Power of Buyers
5.5 Beta Glucan Market Intensity of Competitive Rivalry
5.6 Beta Glucan Market Threat of Substitutes
6. Global Beta Glucan Market Data – Industry Size, Share, and Outlook
6.1 Beta Glucan Market Annual Sales Outlook, 2025- 2034 ($ Million)
6.1 Global Beta Glucan Market Annual Sales Outlook by Type, 2025- 2034 ($ Million)
6.2 Global Beta Glucan Market Annual Sales Outlook by Application, 2025- 2034 ($ Million)
6.3 Global Beta Glucan Market Annual Sales Outlook by End-User, 2025- 2034 ($ Million)
6.4 Global Beta Glucan Market Annual Sales Outlook by Region, 2025- 2034 ($ Million)
7. Asia Pacific Beta Glucan Industry Statistics – Market Size, Share, Competition and Outlook
7.1 Asia Pacific Market Insights, 2024
7.2 Asia Pacific Beta Glucan Market Revenue Forecast by Type, 2025- 2034 (USD Million)
7.3 Asia Pacific Beta Glucan Market Revenue Forecast by Application, 2025- 2034(USD Million)
7.4 Asia Pacific Beta Glucan Market Revenue Forecast by End-User, 2025- 2034 (USD Million)
7.5 Asia Pacific Beta Glucan Market Revenue Forecast by Country, 2025- 2034 (USD Million)
7.5.1 China Beta Glucan Analysis and Forecast to 2034
7.5.2 Japan Beta Glucan Analysis and Forecast to 2034
7.5.3 India Beta Glucan Analysis and Forecast to 2034
7.5.4 South Korea Beta Glucan Analysis and Forecast to 2034
7.5.5 Australia Beta Glucan Analysis and Forecast to 2034
7.5.6 Indonesia Beta Glucan Analysis and Forecast to 2034
7.5.7 Malaysia Beta Glucan Analysis and Forecast to 2034
7.5.8 Vietnam Beta Glucan Analysis and Forecast to 2034
7.6 Leading Companies in Asia Pacific Beta Glucan Industry
8. Europe Beta Glucan Market Historical Trends, Outlook, and Business Prospects
8.1 Europe Key Findings, 2024
8.2 Europe Beta Glucan Market Size and Percentage Breakdown by Type, 2025- 2034 (USD Million)
8.3 Europe Beta Glucan Market Size and Percentage Breakdown by Application, 2025- 2034 (USD Million)
8.4 Europe Beta Glucan Market Size and Percentage Breakdown by End-User, 2025- 2034 (USD Million)
8.5 Europe Beta Glucan Market Size and Percentage Breakdown by Country, 2025- 2034 (USD Million)
8.5.1 2024 Germany Beta Glucan Market Size and Outlook to 2034
8.5.2 2024 United Kingdom Beta Glucan Market Size and Outlook to 2034
8.5.3 2024 France Beta Glucan Market Size and Outlook to 2034
8.5.4 2024 Italy Beta Glucan Market Size and Outlook to 2034
8.5.5 2024 Spain Beta Glucan Market Size and Outlook to 2034
8.5.6 2024 BeNeLux Beta Glucan Market Size and Outlook to 2034
8.5.7 2024 Russia Beta Glucan Market Size and Outlook to 2034
8.6 Leading Companies in Europe Beta Glucan Industry
9. North America Beta Glucan Market Trends, Outlook, and Growth Prospects
9.1 North America Snapshot, 2024
9.2 North America Beta Glucan Market Analysis and Outlook by Type, 2025- 2034($ Million)
9.3 North America Beta Glucan Market Analysis and Outlook by Application, 2025- 2034($ Million)
9.4 North America Beta Glucan Market Analysis and Outlook by End-User, 2025- 2034($ Million)
9.5 North America Beta Glucan Market Analysis and Outlook by Country, 2025- 2034($ Million)
9.5.1 United States Beta Glucan Market Analysis and Outlook
9.5.2 Canada Beta Glucan Market Analysis and Outlook
9.5.3 Mexico Beta Glucan Market Analysis and Outlook
9.6 Leading Companies in North America Beta Glucan Business
10. Latin America Beta Glucan Market Drivers, Challenges, and Growth Prospects
10.1 Latin America Snapshot, 2024
10.2 Latin America Beta Glucan Market Future by Type, 2025- 2034($ Million)
10.3 Latin America Beta Glucan Market Future by Application, 2025- 2034($ Million)
10.4 Latin America Beta Glucan Market Future by End-User, 2025- 2034($ Million)
10.5 Latin America Beta Glucan Market Future by Country, 2025- 2034($ Million)
10.5.1 Brazil Beta Glucan Market Analysis and Outlook to 2034
10.5.2 Argentina Beta Glucan Market Analysis and Outlook to 2034
10.5.3 Chile Beta Glucan Market Analysis and Outlook to 2034
10.6 Leading Companies in Latin America Beta Glucan Industry
11. Middle East Africa Beta Glucan Market Outlook and Growth Prospects
11.1 Middle East Africa Overview, 2024
11.2 Middle East Africa Beta Glucan Market Statistics by Type, 2025- 2034 (USD Million)
11.3 Middle East Africa Beta Glucan Market Statistics by Application, 2025- 2034 (USD Million)
11.4 Middle East Africa Beta Glucan Market Statistics by End-User, 2025- 2034 (USD Million)
11.5 Middle East Africa Beta Glucan Market Statistics by Country, 2025- 2034 (USD Million)
11.5.1 South Africa Beta Glucan Market Outlook
11.5.2 Egypt Beta Glucan Market Outlook
11.5.3 Saudi Arabia Beta Glucan Market Outlook
11.5.4 Iran Beta Glucan Market Outlook
11.5.5 UAE Beta Glucan Market Outlook
11.6 Leading Companies in Middle East Africa Beta Glucan Business
12. Beta Glucan Market Structure and Competitive Landscape
12.1 Key Companies in Beta Glucan Business
12.2 Beta Glucan Key Player Benchmarking
12.3 Beta Glucan Product Portfolio
12.4 Financial Analysis
12.5 SWOT and Financial Analysis Review
14. Latest News, Deals, and Developments in Beta Glucan Market
14.1 Beta Glucan trade export, import value and price analysis
15 Appendix
15.1 Publisher Expertise
15.2 Beta Glucan Industry Report Sources and Methodology
At OG Analysis, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from OG Analysis. Experience the caliber of insights that can transform the way you approach your business challenges.
The Global Beta Glucan Market is estimated to generate USD 746.4 million in revenue in 2025
The Global Beta Glucan Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period from 2025 to 2034.
The Beta Glucan Market is estimated to reach USD 1,451.2 million by 2034.
$3950- 20%
$5850- 25%
$7850- 30%
$2850- 10%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!